Document Detail


Enhanced suppressive function of regulatory T cells from patients with immune-mediated diseases following successful ex vivo expansion.
MedLine Citation:
PMID:  20472506     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Recent studies and our current data demonstrated the deficits in the numbers and/or functions of the CD4(+)CD25(+)Foxp3(+) Treg cells in the patients with autoimmune diseases, indicating that restoration of Treg cells in these patients could be a potential therapeutic approach. Here, we demonstrated that CD4(+)CD25(+)Foxp3(+) Treg cells can be purified, activated and expanded from peripheral blood of patients with immune-mediated diseases, to a similar degree to those from healthy donors. Within 3weeks, Treg cells from most patients could be expanded ex vivo 100-2000 fold and maintained their phenotypic characteristics. Furthermore, ex vivo expanded Treg cells displayed potent and enhanced in vitro suppressive activities inhibiting T effector cell proliferation compared to Treg cells freshly purified from the same patients. The expanded Treg cells with enhanced biological function may provide an opportunity to restore the proper balance of immunity and tolerance, suggesting the potential of using Treg cell therapy for treatment of immune-mediated diseases.
Authors:
Tinghua Cao; Sally E Wenzel; William A Faubion; Gregory Harriman; Li Li
Related Documents :
20729906 - Cd4+ cd25+ but not cd4+ foxp3+ t cells as a regulatory subset in primary biliary cirrho...
20736096 - Regulatory t cell immunotherapy for transplantation tolerance: step into clinic.
18254876 - L-theanine intervention enhances human gammadeltat lymphocyte function.
18384776 - Cxcl12 enhances exogenous cd4+cd25+ t cell migration and prevents embryo loss in non-ob...
20729906 - Cd4+ cd25+ but not cd4+ foxp3+ t cells as a regulatory subset in primary biliary cirrho...
3128036 - Expression of cd9 (p24) antigen on hematopoietic cells following treatment with phorbol...
Publication Detail:
Type:  In Vitro; Journal Article     Date:  2010-05-15
Journal Detail:
Title:  Clinical immunology (Orlando, Fla.)     Volume:  136     ISSN:  1521-7035     ISO Abbreviation:  Clin. Immunol.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-06     Completed Date:  2010-08-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883537     Medline TA:  Clin Immunol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  329-37     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier Inc. All rights reserved.
Affiliation:
Therakos Inc., 1001 US Route 202, Raritan, NJ 08869, USA. tcao4@its.jnj.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arthritis, Rheumatoid / immunology,  therapy
Asthma / immunology,  therapy
Autoimmune Diseases / immunology*,  therapy*
Case-Control Studies
Colitis, Ulcerative / immunology,  therapy
Crohn Disease / immunology,  therapy
Humans
Immunosuppression / methods
Immunotherapy / methods
Inflammation / immunology*,  therapy*
Lupus Erythematosus, Systemic / immunology,  therapy
Lymphocyte Activation
Multiple Sclerosis, Relapsing-Remitting / immunology,  therapy
Self Tolerance
T-Lymphocytes, Regulatory / immunology*,  transplantation*
Transplantation, Autologous

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/veloca...
Next Document:  Use of complex three-dimensional objects to assess visuospatial memory in healthy individuals and pa...